Clinical Trial Update: NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study [Phase 1, Phase 2]

View source ↗

Summary

This study investigates NECIM, a Phase 1/2 feasibility trial of neoadjuvant chemotherapy plus immunotherapy for selected inoperable pleural mesothelioma patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Pleural Epithelioid Mesothelioma, Mesothelioma; Pleura | Phase 1, Phase 2 | Status: RECRUITING